RRBI:NASDAQRed River Bancshares, Inc. Analysis
Data as of 2026-04-29 - not real-time
$95.10
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Red River Bancshares is trading at $95.1, comfortably above its 20‑day SMA of 93.75 and 50‑day SMA of 90.81, indicating a short‑term bullish bias. The RSI sits at 60.5, well within the neutral zone, while the MACD shows a bearish crossover (line below signal, histogram –0.21), suggesting modest downside pressure. Valuation metrics are attractive: the trailing P/E of 14.9 is below the industry average of 17.5 and the DCF‑derived fair value of $144.8 implies significant upside. Revenue growth of 13.5% and an operating margin of 44.9% demonstrate solid earnings momentum, and the dividend yield of 0.7% is supported by a low payout ratio of 8.5%.
Liquidity is moderate with average daily volume around 60k and a decreasing volume trend, while the stock’s beta of roughly 0.8 and 30‑day volatility of 21.6% point to medium risk. The balance sheet is strong, featuring $213M in cash against negligible debt, and a book‑value per share of $55.5. Recent material news includes a quarterly dividend increase and a private stock repurchase, both reinforcing shareholder‑friendly capital allocation. Overall, the combination of undervaluation, growth fundamentals, and a sustainable dividend supports a positive outlook despite the slight bearish technical signal.
Liquidity is moderate with average daily volume around 60k and a decreasing volume trend, while the stock’s beta of roughly 0.8 and 30‑day volatility of 21.6% point to medium risk. The balance sheet is strong, featuring $213M in cash against negligible debt, and a book‑value per share of $55.5. Recent material news includes a quarterly dividend increase and a private stock repurchase, both reinforcing shareholder‑friendly capital allocation. Overall, the combination of undervaluation, growth fundamentals, and a sustainable dividend supports a positive outlook despite the slight bearish technical signal.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above 20‑ and 50‑day SMAs indicating bullish bias
- Bearish MACD crossover and decreasing volume adding caution
- Support level near $89 providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to peers (P/E 14.9 vs industry 17.5)
- Revenue growth of 13.5% and strong operating margins
- Dividend increase and low payout ratio supporting cash flow
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust balance sheet with high cash and negligible debt
- DCF fair value of $144.8 suggesting long‑run upside
- Sustainable dividend and consistent earnings generation
Key Metrics & Analysis
Financial Health
Revenue Growth13.50%
Profit Margin34.71%
P/E Ratio14.9
ROE12.49%
ROA1.32%
P/B Ratio1.7
Op. Cash Flow$44.8M
Industry P/E17.5
Technical Analysis
TrendBullish
RSI60.5
Support$89.04
Resistance$98.85
MA 20$93.75
MA 50$90.81
MA 200$74.44
MACDBearish
VolumeDecreasing
Fear & Greed Index89.59
Valuation
Fair Value$144.83
Target Price$101.00
Upside/Downside6.20%
GradeUndervalued
TypeBlend
Dividend Yield0.70%
Risk Assessment
Beta0.82
Volatility21.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.